|
Re: BETonMACE Enrollment
|
4
|
Resverlogix Corp.
|
Feb 08, 2019 11:03PM
|
|
Re: BETonMACE Enrollment....and another question for BDZ
|
4
|
Resverlogix Corp.
|
Feb 08, 2019 05:31PM
|
|
Re: Top scientific things that indicate that BETonMACE will be successful
|
3
|
Resverlogix Corp.
|
Feb 08, 2019 02:33PM
|
|
Re: Top scientific things that indicate that BETonMACE will be successful
|
5
|
Resverlogix Corp.
|
Feb 08, 2019 12:17PM
|
|
Re: BETonMACE Enrollment
|
4
|
Resverlogix Corp.
|
Feb 08, 2019 10:07AM
|
|
Re: Primate/Monkey Studies / Financing
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 07, 2019 12:42PM
|
|
Re: Primate/Monkey Studies / Financing
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 07, 2019 12:03PM
|
|
Re: Next private placement/licensing agreement
|
3
|
Resverlogix Corp.
|
Feb 07, 2019 11:24AM
|
|
Re: Primate/Monkey Studies / Financing
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 06, 2019 04:49PM
|
|
Re: Next private placement/licensing agreement
|
8
|
Resverlogix Corp.
|
Feb 06, 2019 12:29PM
|
|
Re: Little help? Short interest
|
2
|
Resverlogix Corp.
|
Feb 06, 2019 11:59AM
|
|
Macrogenic's Margetuximab
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 06, 2019 11:57AM
|
|
Re: BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
|
2
|
Zenith Epigenetics
|
Feb 06, 2019 09:52AM
|
|
BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
|
1
|
Zenith Epigenetics
|
Feb 05, 2019 05:28PM
|
|
Re: 2019 Potential Events
|
4
|
Resverlogix Corp.
|
Feb 05, 2019 04:54PM
|
|
Re: Nasdaq!!
|
2
|
Resverlogix Corp.
|
Feb 05, 2019 04:02PM
|
|
Re: 2019 Potential Events
|
2
|
Resverlogix Corp.
|
Feb 05, 2019 01:29PM
|
|
AD/PD 2019 March 26-31, 2019
|
4
|
Resverlogix Corp.
|
Feb 05, 2019 01:28PM
|
|
Re: New Fact Sheet
|
1
|
Resverlogix Corp.
|
Feb 05, 2019 01:28PM
|
|
Bromodomain-containi... proteins in prostate cancer
|
2
|
Zenith Epigenetics
|
Feb 05, 2019 10:37AM
|
